Flunarizine as add-on therapy in refractory epilepsy: An open trial

We evaluated flunarizine as add-on therapy for control of refractory epilepsy in an open trial in 17 patients. Children received 10 mg/day and adults received 20 mg/day of flunarizine for 6 months. In eight patients, antiepileptic drug (AED) serum levels at baseline and at 3 months of flunarizine th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of epilepsy 1996-04, Vol.9 (1), p.20-22
Main Authors: Agarwal, V.K., Jain, Satish, Vaswani, M., Padma, M.V., Maheshwari, M.C.
Format: Article
Language:English
Subjects:
Flunarizine
Refractory epilepsy
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated flunarizine as add-on therapy for control of refractory epilepsy in an open trial in 17 patients. Children received 10 mg/day and adults received 20 mg/day of flunarizine for 6 months. In eight patients, antiepileptic drug (AED) serum levels at baseline and at 3 months of flunarizine therapy were available. Six of the 17 patients had seizure reduction ⩾50%. Three of six had generalized tonic-clonic seizures (GTCS). Most of remaining patients were unchanged or had increased complex partial seizures (CPS). Three of the six patients with ⩾50% seizure reduction were treated with phenobarbital (PB) and phenytoin (PHT) combination. Addition of flunarizine caused no significant alteration in baseline serum AED levels. With the addition of flunarizine, seizure control in patients with GTCS was better than that of patients with CPS. Patients receiving combination PB and PHT treatment responded better with the addition of flunarizine than did those receiving other AED combinations. We conclude that flunarizine had some antiepileptic property as add-on therapy in 35% of our cases with refractory epilepsy.
ISSN:0896-6974
DOI:10.1016/0896-6974(95)00068-2